医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Acromegalic arthropathy (E22.000x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Pituitary growth-hormone adenoma (E22.000x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compile
Excessive growth-hormone production (E22.000x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Pituitary gigantism (E22.000x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Acromegaly and pituitary gigantism (E22.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Parathyroid disorder (E21.500) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Parathyroid-cyst hemorrhage (E21.402) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Parathyroid cyst (E21.401) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Parathyroiditis (E21.400x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Parathyroid hemorrhage (E21.400x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other specified parathyroid disorders (E21.400) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Hyperparathyroid crisis (E21.301) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Hyperparathyroidism with myopathy (E21.300x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Hyperparathyroid crystal arthropathy (E21.300x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being com
Elevated parathyroid hormone (E21.300x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Hyperparathyroidism is excess PTH from parathyroid adenoma/hyperplasia (primary) or chronic renal failure/vitamin-D deficiency (secondary); causes hypercalcemia/bone disease; tertiary = autonomous after secondary.
内分泌科Hyperparathyroidism (E21.300) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tertiary hyperparathyroidism (E21.201) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other hyperparathyroidism (E21.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Secondary hyperparathyroidism (E21.100x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
